<?xml version="1.0" encoding="UTF-8"?>
<p>With respect to the use of protease inhibitors during pregnancy, such as lopinavir, some teams have reported an increased risk of preterm delivery. However, a specific analysis of more than 4000 pregnant women found a similar incidence and rate of adverse pregnancy outcomes compared with controls at all three trimesters of pregnancy, including preterm birth, low birthweight and birth defects.
 <xref rid="bjo16270-bib-0031" ref-type="ref">
  <sup>31</sup>
 </xref>
</p>
